FdaApplication
ANDA 212226
Identifiers
- fda_app_no: ANDA212226
Properties
| Property | Value |
|---|---|
| applicant_name | SPECGX LLC |
| application_type | ANDA |
| approval_date | 2022-05-10 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| POSACONAZOLE | POSACONAZOLE | 100MG | TABLET, DELAYED RELEASE;ORAL |
1 product